Back

Terminal1 adds BioStem Technologies to shareholder intelligence platform

Verifying
  • Terminal1 added BioStem Technologies to its platform for public companies.
  • BioStem will use tools covering shareholder data, investor communications and engagement analytics.
  • Terminal1 continues expanding capabilities across investor relations infrastructure and public-company services.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.